Replies to post #337975 on Anavex Life Sciences Corp (AVXL)

[Talon38]

Think "Keytruda".

[Bourbon_on_my_cornflakes]

AGREE: Missling is intensely focused. Missling has been frugal and has only pursued indications with strong preclinical results.

He as also been great at finding non-dilutive financing in Australia, foundations and EU

[ExtremelyBullishZig]

Not under estimating anything. Nothing you said matters. If you have a ton of trials going on at once, you are not focused. Sorry...not with a small company that isn't big enough to have different departments. There is a lot more work to do and it take a lot more capital raises instead of using profit in the future for some of these. The number of trials and indications that are going to be started on our dime and not with profit is starting to get ridiculous. Spend money and time on a 3 indications max. In a few months we will be spread so thin (6, 7, 8 indications) and not even 1 approved. No wonder they don't really understand their MOA. They are doing too many other things. They are spread too thin... period.